Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,284 across all filing types
Latest filing 2024-12-13 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
第五届董事会第二十次(临时)会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board of directors meeting of Tianjin Ruipu Biotechnology Co., Ltd. It includes information about the meeting date, attendance, agenda items such as acquisitions, related party transactions, company name change, amendments to the articles of association, and the scheduling of a shareholders meeting. The document does not contain financial statements or detailed financial performance data. It is a formal disclosure of board decisions and management-level corporate governance matters. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2715 characters, which is consistent with a meeting resolution announcement rather than a full report or regulatory filing.
2024-12-13 Chinese
天津中瑞供应链管理有限公司审计报告及财务报表
Audit Report / Information Classification · 95% confidence The document is titled '审计报告及财务报表' which translates to 'Audit Report and Financial Statements' for the fiscal year 2023 and the period up to October 31, 2024. It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. The text includes an auditor's opinion section, basis for the audit opinion, management's responsibility, and auditor's responsibility, which are typical components of an audit report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial data and audit opinion confirms this is a standalone audit report rather than a full annual report or interim report. Therefore, the document fits the category of Audit Report / Information (AR). 9M 2024
2024-12-13 Chinese
关于修改公司章程的公告
Governance Information Classification · 95% confidence The document is an announcement regarding the amendment of the company's articles of association (公司章程). It details specific changes to the company's registered name and related clauses in the articles. The document is short (1040 characters) and serves as a formal notice of these changes and the upcoming shareholder meeting to approve them. It does not contain financial data, audit information, or detailed reports. It is not a full report but an announcement of governance-related changes. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-12-13 Chinese
关于拟收购天津中瑞供应链管理有限公司部分股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the proposed acquisition of a 56.3129% equity stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. by Tianjin Ruipu Biotechnology Co., Ltd. It includes transaction details, pricing, related party relationships, financial data, and approvals from the board and independent directors. The document is not a full financial report but an announcement of a significant capital transaction involving acquisition and related party dealings. It does not contain comprehensive financial statements or quarterly/yearly financial results but focuses on the acquisition and related transaction disclosures. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8928 characters) and content confirm it is a full announcement, not a brief notice or a report publication announcement.
2024-12-13 Chinese
瑞派宠物医院管理股份有限公司拟进行股权转让所涉及的天津中瑞供应链管理有限公司股东全部权益价值项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is an asset valuation report related to a proposed equity transfer involving 瑞派宠物医院管理股份有限公司 and 天津中瑞供应链管理有限公司. It contains detailed asset evaluation, shareholder structure, financial data, and valuation conclusions. The report is titled as an "资产评估报告" (Asset Evaluation Report) and includes valuation methods, assumptions, and conclusions. It is not a general annual or interim financial report, nor is it an announcement or certification. It is a standalone asset evaluation report prepared by an asset evaluation company, which fits the category of Audit Report / Information (AR) as it involves applied accounting principles and valuation results related to a specific transaction. The document length is substantial (15,000 characters), and it contains substantive financial and valuation data, not merely an announcement or summary. Therefore, the appropriate classification is AR (Audit Report / Information). 9M 2024
2024-12-13 Chinese
关于召开2024年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2024 second extraordinary general meeting of shareholders for Tianjin Ringpu Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be voted on, registration details, and proxy voting instructions. There is no financial data, earnings information, or audit content. The document is not a report but a formal announcement and invitation to shareholders to participate in the meeting and vote on specific proposals. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2024-12-13 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.